Summit Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Summit Biosciences's estimated annual revenue is currently $23.5M per year.
- Summit Biosciences's estimated revenue per employee is $201,000
Employee Data
- Summit Biosciences has 117 Employees.
- Summit Biosciences grew their employee count by 0% last year.
Summit Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Accounting Officer | Reveal Email/Phone |
2 | Director Pharmaceutical Development | Reveal Email/Phone |
3 | Director Operations | Reveal Email/Phone |
4 | Chief Business Officer | Reveal Email/Phone |
5 | President and Chief Operating Officer | Reveal Email/Phone |
6 | Associate Director Human Resources | Reveal Email/Phone |
7 | Director, Supply Chain Management | Reveal Email/Phone |
8 | Director Quality | Reveal Email/Phone |
9 | Senior Manager, Analytical Sciences | Reveal Email/Phone |
10 | QC Chemistry Manager | Reveal Email/Phone |
Summit Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.4M | 42 | 0% | N/A | N/A |
#2 | $970.9M | 3019 | 5% | $47.1M | N/A |
#3 | $1.4M | 7 | 0% | N/A | N/A |
#4 | $21.9M | 109 | -5% | N/A | N/A |
#5 | $12.9M | 64 | 25% | N/A | N/A |
#6 | $14.7M | 87 | 9% | N/A | N/A |
#7 | $15.1M | 75 | 6% | N/A | N/A |
#8 | $109.9M | 547 | 23% | N/A | N/A |
#9 | $12.3M | 61 | 5% | N/A | N/A |
#10 | $76.2M | 379 | 0% | N/A | N/A |
What Is Summit Biosciences?
Our vision is to be recognized as the leader in the field of intranasal pharmaceutical drug products development and manufacturing. We intend to accomplish this by applying our unique formulation and manufacturing expertise and by leveraging our state-of-the-art cGMP manufacturing facility and our high-speed nasal products manufacturing and packaging equipment to address a high-growth, niche market.
keywords:N/A
N/A
Total Funding
117
Number of Employees
$23.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Summit Biosciences News
The historic S.E.E. Summit (Safer, Easier, Earlier) is a free, virtual event ... Natera, Pillar Biosciences and StageZero Life Sciences.
Serhat Gumrukçu, the inventor and co-founder of the Company, delivered the concluding Plenary Lecture at the Innate Killer Summit in San Diego,...
SHORELINE BIOSCIENCES ANNOUNCES ORAL PRESENTATION on ipsc-derived NK cell (iNK) platform AT INNATE KILLER SUMMIT meeting 2022.
Other Companies in Lexington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $39.7M | 121 | -10% | N/A |
#2 | $22.5M | 125 | 21% | N/A |
#3 | $30.9M | 126 | 2% | N/A |
#4 | $25.7M | 128 | 60% | N/A |
#5 | $20M | 129 | -16% | N/A |